In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic‐guided Dosing of Efanesoctocog Alfa in Haemophilia A Patients
Authors
Ron A. A. Mathôt (ORCID: https://orcid.org/0000-0001-8401-0879)
Marjon H. Cnossen (ORCID: https://orcid.org/0000-0003-1557-2995)
Jan den Hollander (ORCID: https://orcid.org/0009-0001-5883-0475)
Institutions
Amsterdam UMC Location University of Amsterdam (NL)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Nederlandse Vereniging voor Trombose en Hemostase
Swedish Orphan Biovitrum
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic‐guided Dosing of Efanesoctocog Alfa in Haemophilia A Patients
Ron A. A. Mathôt, Marjon H. Cnossen, Jan den Hollander
Journal
Haemophilia
Topics
Hemophilia Treatment and Research
article
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic‐guided Dosing of Efanesoctocog Alfa in Haemophilia A Patients
Ron A. A. Mathôt, Marjon H. Cnossen, Jan den Hollander
article en
Abstract
No abstract available for this paper.
Publication Tag
HaemophiliaVol. 32(1)
Institutions
Amsterdam UMC Location University of Amsterdam (NL), Erasmus MC - Sophia Children’s Hospital (NL)
Funders
CSL Behring, Amsterdam University Medical Centers, Universiteit Leiden, Radboud Universiteit, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Nederlandse Vereniging voor Trombose en Hemostase, Swedish Orphan Biovitrum